Non-cardiomyocyte microRNAs in heart failure

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• RNA Biology

Background:

• Heart failure (HF) involves complex structural changes in the myocardium, including myocyte hypertrophy, apoptosis, fibrosis, and altered vascularization.
• The molecular underpinnings of these myocardial changes are actively investigated, with numerous signaling pathways identified.
• MicroRNAs (miRNAs), a class of small non-coding RNAs, have recently emerged as critical regulators in cardiac remodeling.

Purpose of the Study:

• To review the current understanding of miRNA roles in the non-myocyte components of the heart.
• To elucidate the specific functions of miRNAs in cardiac fibroblasts, endothelial cells, and immune cells during myocardial stress and HF pathogenesis.

Main Methods:

• Literature review of studies investigating miRNA involvement in cardiac structural changes.
• Analysis of research focusing on miRNA expression and function in non-myocyte cell types within the heart.
• Synthesis of findings related to myocardial infarction and heart failure models.

Main Results:

• miRNAs significantly impact the behavior of cardiac fibroblasts, influencing interstitial fibrosis.
• Endothelial cell function and capillary density are modulated by specific miRNAs, affecting cardiac vascularization.
• Immune cell activation and inflammatory responses in the heart are regulated by miRNAs during HF progression.

Conclusions:

• miRNAs are pivotal regulators of structural remodeling in the failing heart, acting through non-myocyte cell populations.
• Targeting non-myocyte-specific miRNAs offers a promising therapeutic avenue for treating heart failure.
• Further research into miRNA mechanisms in cardiac fibroblasts, endothelial cells, and immune cells is essential for developing effective HF interventions.